Despina Contopoulos-Ioannidis, MD
Academic Appointments
- Clinical Associate Professor, Pediatrics - Infectious Diseases
Key Documents
Contact Information
-
Clinical Offices
300 Pasteur Drive G312 Stanford, CA 94305 Tel Work (650) 723-5682 Fax (650) 725-8040Practices at Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 853-6013
Professional Overview
Clinical Focus
- Pediatric Infectious Disease
- Infectious Diseases
- Toxoplasmosis
- Antibiotics and Weight Gain
- General Pediatrics
Administrative Appointments
- Clinical Associate Professor, Clinician Educator Line, Stanford University School of Medicine, Dept of Pediatrics-Division of Infectious Diseases (2011 - present)
- Clinical Associate Professor, Clinician Educator Line, Stanford University School of Medicine, Dept of Medicine-Division of Infectious Diseases and Geographic Medicine (2010 - 2011)
- Medical Consultant,Toxoplasma Serology Laboratory, PAMF Research Institute, Palo Alto, CA (2010 - present)
- Consulting Investigator, Health Policy Research, Palo Alto Medical Foundation Research Institute (2011 - present)
Professional Education
| Certificate (MOC): | American Board of Pediatrics-Subspecialty of Pediatric Infectious Diseases, Pediatric Infectious Diseases (2011) |
| Certificate (MOC): | American Board of Pediatrics, General Pediatrics (2010) |
| Board Certification: | Pediatric Infectious Disease, American Board of Pediatrics (1999) |
| Medical Education: | University of Athens Medical School, Greece (10/1990) |
| Residency: | Saint Demetrios Hospital of Thessaloniki, Greece (04/1992) |
| Residency: | Peripheral General Hospital of Athens, Greece (12/1991) |
Scientific Focus
Current Research Interests
Evidence based medicine, systematic reviews and meta-analyses in infectious diseases and general medical topics.
Chronic Antibiotic Use and Weight Gain: a 10 year retrospective cohort study
Comparative effectiveness of medical interventions in adults vs children
Comparative effectiveness of medical interventions:evidence from RCTs from developing countires vs. established market economies
Comparative appraisal of harms of medical interventions in adults vs children
Comparative safety of medical interventions:evidence from RCTs from developing countires vs. established market economies
Family outbreaks of acute toxoplasmosis in the US (A prospective cohort study/ Retrospective cohort analysis)
Seasonality patterns of acute toxoplasmosis in the US;
Improving Laboratory Diagnosis of Congenital Toxoplasmosis;
Trends in intussusception in the US (association with pediatric vaccines)
Empirical appraisal of CEA for pediatric vaccines (with and without inclusion of herd immunity assumptions)
Patient safety related empirical projects: evaluation of the drug “black box warning” labeling.
Empirical evaluation of the research agenda of meta-analyses.
Multidomain empirical evaluation of the proposed efficacy of systemic steroids over the last 35 years.
Appraisal of the use of quality of life instruments in randomized clinical trials
Empirical multidomain evaluation of the life cycle of translational research for medical interventions.
Publications
- Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment. BMJ. 2013: f707
- Most meta-analyses of drug interventions have narrow scopes and many focus on specific agents. J Clin Epidemiol. 2013; (4): 371-8
- Patient safety strategies targeted at diagnostic errors: a systematic review. Ann Intern Med. 2013; (5 Pt 2): 381-9
- Claims for improved survival from systemic corticosteroids in diverse conditions: an umbrella review. Eur J Clin Invest. 2012; (3): 233-44
- Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses. Pediatrics. 2012: S161-84
- Standard 6: age groups for pediatric trials. Pediatrics. 2012: S153-60
Help